ZA852591B - Pyridine derivatives and production thereof - Google Patents

Pyridine derivatives and production thereof

Info

Publication number
ZA852591B
ZA852591B ZA852591A ZA852591A ZA852591B ZA 852591 B ZA852591 B ZA 852591B ZA 852591 A ZA852591 A ZA 852591A ZA 852591 A ZA852591 A ZA 852591A ZA 852591 B ZA852591 B ZA 852591B
Authority
ZA
South Africa
Prior art keywords
production
pyridine derivatives
vasodilating
formulaand
dihydropyridine
Prior art date
Application number
ZA852591A
Other languages
English (en)
Inventor
Kiyoshi Kimura
Iwao Morita
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of ZA852591B publication Critical patent/ZA852591B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA852591A 1984-04-19 1985-04-04 Pyridine derivatives and production thereof ZA852591B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59079560A JPS60248693A (ja) 1984-04-19 1984-04-19 ピリジン誘導体及び製法

Publications (1)

Publication Number Publication Date
ZA852591B true ZA852591B (en) 1986-01-29

Family

ID=13693390

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852591A ZA852591B (en) 1984-04-19 1985-04-04 Pyridine derivatives and production thereof

Country Status (15)

Country Link
US (1) US5036059A (fr)
EP (1) EP0159040B1 (fr)
JP (1) JPS60248693A (fr)
KR (1) KR850007603A (fr)
AT (1) ATE83237T1 (fr)
AU (1) AU570552B2 (fr)
BE (1) BE902210A (fr)
DE (1) DE3586879D1 (fr)
ES (1) ES8606276A1 (fr)
FR (1) FR2563222B1 (fr)
GB (1) GB2157695A (fr)
IT (1) IT1209945B (fr)
NL (1) NL8500909A (fr)
SE (1) SE464028B (fr)
ZA (1) ZA852591B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6163688A (ja) * 1984-08-03 1986-04-01 Nissan Chem Ind Ltd ジヒドロピリジン−5−ホスホン酸環状エステル類
CN1016063B (zh) 1986-01-22 1992-04-01 日产化学工业株式会社 二氢吡啶-5-膦酸环亚丙基酯的制备
US4885284A (en) * 1986-01-22 1989-12-05 Nissan Chemical Industries Ltd. Dihydropyridine-5-phosphonic acid cyclic propylene ester
UA5590A1 (uk) * 1986-01-23 1994-12-28 Ніссан Кемікал Індастріз Лтд Спосіб одержання пропіленглікового ефіру заміщеної 1,4-дігідропіріділ-5-фосфорної кислоти, або його фармацевтично прийнятной солі або сольвата
JPS63115890A (ja) * 1986-10-31 1988-05-20 Nippon Shinyaku Co Ltd 2位置換1,4−ジヒドロピリジン誘導体
JPH01275591A (ja) * 1988-04-27 1989-11-06 Nissan Chem Ind Ltd ジヒドロピリジン−5−ホスホン酸誘導体
JP2850376B2 (ja) * 1988-08-02 1999-01-27 日産化学工業株式会社 抗癌剤薬効増強剤
ATE128623T1 (de) * 1988-08-02 1995-10-15 Nissan Chemical Ind Ltd Mittel zur verbesserung von arzneimitteleffekten für antitumormittel.
US20020119201A1 (en) * 2000-09-08 2002-08-29 Novozymes A/S Lubricated granules
AU2004226547B2 (en) 2003-03-28 2008-10-23 Nissan Chemical Industries,Ltd. T-Type calcium channel blockers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2094678A5 (fr) * 1970-06-30 1972-02-04 Pepro
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS59161392A (ja) * 1983-03-04 1984-09-12 Nippon Shinyaku Co Ltd ジヒドロピリジン誘導体及びその製法
EP0141222B1 (fr) * 1983-09-26 1989-04-12 Nissan Chemical Industries Ltd. Ester cyclique de l'acide dihydropyridine-phosphonique-5

Also Published As

Publication number Publication date
GB8507897D0 (en) 1985-05-01
DE3586879D1 (de) 1993-01-21
SE8501882L (sv) 1985-10-20
ES8606276A1 (es) 1986-04-01
AU4140585A (en) 1985-10-24
FR2563222A1 (fr) 1985-10-25
JPS60248693A (ja) 1985-12-09
IT8547862A0 (it) 1985-03-25
FR2563222B1 (fr) 1989-06-09
BE902210A (fr) 1985-10-17
KR850007603A (ko) 1985-12-07
EP0159040A3 (en) 1988-08-17
JPH0259835B2 (fr) 1990-12-13
IT1209945B (it) 1989-08-30
ATE83237T1 (de) 1992-12-15
AU570552B2 (en) 1988-03-17
SE8501882D0 (sv) 1985-04-17
EP0159040A2 (fr) 1985-10-23
EP0159040B1 (fr) 1992-12-09
ES542378A0 (es) 1986-04-01
SE464028B (sv) 1991-02-25
NL8500909A (nl) 1985-11-18
US5036059A (en) 1991-07-30
GB2157695A (en) 1985-10-30

Similar Documents

Publication Publication Date Title
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
EP0161877A3 (en) 1,4-dihydropyridine derivatives, methods for their production and pharmaceutical compositions comprising the same
ATE40365T1 (de) 3-acylaminomethylimidazo (1,2-a> pyridine, dessen herstellung und therapeutische anwendung.
ES8701717A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido (5-amino-2-hidroxi)benzoico.
YU47121B (sh) Postupak za dobijanje 2-3-dideoksi-2-fluoro-nukleozid'a
IL51213A0 (en) The production of 4,4'-isopropylidene-bis-(2,6-dibromophenol)
ZA852591B (en) Pyridine derivatives and production thereof
DE3866686D1 (de) Verwendung von polysulfatierten heparinen.
IE41440L (en) Thiatetracyclines
ES456243A1 (es) Un procedimiento de preparacion de compuestos de aminoalcoxi4-(2h)-piranona-2, sustituidos en posicion 3 y condensados en posicion 5,6.
ES8503512A1 (es) Complejos de prostaglandinas
ES8607016A1 (es) Preparado solido de nifedipina
NZ214699A (en) 8a-acylaminoergoline derivatives, their production and pharmaceutical compositions
RU1797460C (ru) Нематоцидное средство
ES546136A0 (es) Proceso para producir derivados de 1,4-dihidro-piridina-3,5,dicarboxilato.
IE39049B1 (en) New 1,4-dihydroquinoline derivatives their production and their medicinal use
ES8504779A1 (es) Procedimiento de obtencion de nuevos derivados de 1h-imidazol
JPS52122375A (en) Pyridoxine derivative and its production and medical composition thereof
IL50199A0 (en) The production of 3-hydroxy-1,2,4- triazole derivatives
DE3481769D1 (de) Cephemderivate und ihre herstellung.
DE3579897D1 (de) Cephemderivate und ihre herstellung.
AU505115B2 (en) N, n'diphenyl-guanidine derivatives
ATE40367T1 (de) 4,5,6,7-tetrahydrofuro- oder 1h-pyrrolo (2,3c>pyridinderivate, ihre herstellung und therapeutische verwendung.
ES8105284A1 (es) Procedimiento para preparar indolinas.
HUT39187A (en) Process for separating primicin